DRG Market Assessment 보고서
질환 개요 및 예측, 역학 인텔리전스, 바이오시밀러 인텔리전스, China In-depth 등 폭넓은 시장 인텔리전스를 확인해 보세요.
How Will U.S. Physicians and Payers Respond to Additional LABA/LAMA FDCs in the Increasingly Crowded COPD Market? | Physician & Payer Forum | US | 2015
A Survey of Pulmonologists and Managed Care Organization Pharmacy and Medical Directors The U.S. market for chronic obstructive pulmonary disease (COPD) therapies consists entirely of…
Chronic Kidney Disease (Market Access Challenges Facing Chronic Kidney Disease Treatments) | Physician & Payer Forum | Brazil/Mexico | 2015
A Survey of Medical Nephrologists and Interviews with Payers Chronic kidney disease (CKD) and its underlying conditions (diabetes and hypertension) are among the top causes of disability-…
The Evolving Market Access Landscape for Spondyloarthritis | Physician & Payer Forum | EU5 | 2015
Physician and Payer Perspectives on Biologic Use and Novel Therapeutic Targets in the Treatment of Psoriatic Arthritis, Ankylosing Spondylitis, and Nonradiographic Axial Spondyloarthritis…
Market Access Opportunities and Challenges in Rheumatoid Arthritis | Physician & Payer Forum | EU5 | 2015
A Survey of Rheumatologists and Interviews with Payers in the EU5 Rheumatoid arthritis (RA) is a complex autoimmune condition characterized by chronic and progressive joint inflammation that…
Niche and Rare Solid Tumors (Navigating Reimbursement and Maximizing Market Access) | Physician & Payer Forum | EU5 | 2015
A Survey of Medical Oncologists and Interviews with Payers in the EU5 Hepatocellular carcinoma (HCC), thyroid cancer, gastrointestinal stromal tumor (GIST), and neuroendocrine tumors (NETs) fall…